A cardiologist in Florida has filed a lawsuit against a psychiatrist who performed electroconvulsive therapy while treating him for depression, Courtroom View Network reports.

For the third quarter of 2016, Abbott’s sales increased 2.9 percent to $5.3 billion compared with the same time period last year. The company also posted a $0.24 loss in diluted earnings per share, which it said was primarily due to a $0.66 per share adjustment related to its investment in Mylan.

Shortly after a research firm posted videos Oct. 19 that allegedly showed cybersecurity vulnerabilities with St. Jude Medical’s cardiac devices, the company issued a statement criticizing the release of the videos.

Patients with atrial fibrillation who received cryoballoon catheter ablation had lower healthcare costs and fewer rehospitalizations and repeat ablations compared with those who received radiofrequency ablation, according to a health economic analysis.

Medical device makers are supporting Minnesota Congressman Erik Paulsen in his bid for re-election, STAT reports.

Theranos, the health technology and medical laboratory services company in Palo Alto, California, has already had a slew of problems this year. It’s currently under investigation by the Securities and Exchange Commission and has plans to lay off 340 employees after announcing that it will close laboratories and wellness centers in Arizona, California and Pennsylvania.

St. Jude Medical issued an advisory Oct. 11 warning of premature battery depletion associated with lithium deposits in a small number of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy ICDs.

Theranos founder and CEO Elizabeth Holmes announced on Oct. 5 that the blood testing company would close its laboratories and wellness centers in Arizona, California and Pennsylvania.